Ovid Therapeutics Inc.
SEC CIK 1636651 · OVID · last insider filing 2026-06-17
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Greka Anna | Director | filed 2026 - 2026 |
| Papadopoulos Stelios | Director | filed 2025 - 2026 |
| Friedman Bart | Director | filed 2017 - 2026 |
| Fitzgerald Kevin Joseph | Director | filed 2021 - 2026 |
| Levin Jeremy M | Director · Executive Chairman | filed 2017 - 2026 |
| Duncan Barbara Gayle | Director | filed 2017 - 2026 |
| Bernstein Karen | Director | filed 2017 - 2026 |
| Alexander Margaret A. | Director · President and COO | filed 2024 - 2026 |
| Poole Robert Michael | Director | filed 2021 - 2024 |
| Williams Douglas E | Director | filed 2017 - 2021 |
| During Matthew | Director · President and CSO | filed 2017 - 2019 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Rona Jeffrey A | Chief Business Officer | filed 2020 - 2026 |
| Perone Thomas Michael | SVP, General Counsel | filed 2019 - 2024 |
| Tardio Jason | Chief Operating Officer | filed 2019 - 2024 |
| Rakhit Amit | President and CMO | filed 2017 - 2021 |
| Daly Timothy | VP, Finance & Corp. Controller | filed 2017 - 2020 |
| Haasner Dirk | SVP, Global Regulatory Affairs | filed 2017 - 2020 |
| Ward Ana | SVP and General Counsel | filed 2017 - 2019 |
| Werber Yaron | CBO, CFO, Sec. and Treas. | filed 2017 - 2018 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.